Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.76M Sell
47,853
-1,307
-3% -$151K 1.83% 10
2025
Q4
$5.17M Buy
49,160
+5
+0% +$469 1.42% 12
2025
Q3
$4.13M Sell
49,155
-544
-1% -$44.8K 1.03% 14
2025
Q2
$3.93M Sell
49,699
-2,588
-5% -$206K 0.78% 16
2025
Q1
$4.69M Buy
52,287
+2,930
+6% +$274K 0.91% 12
2024
Q4
$4.91M Sell
49,357
-6,099
-11% -$629K 0.96% 12
2024
Q3
$6.3M Sell
55,456
-346
-0.6% -$41.1K 1.21% 10
2024
Q2
$6.91M Sell
55,802
-272
-0.5% -$35K 1.27% 8
2024
Q1
$7.4M Sell
56,074
-901
-2% -$111K 1.39% 8
2023
Q4
$6.21M Sell
56,975
-294
-0.5% -$30.5K 1.32% 10
2023
Q3
$5.9M Buy
57,269
+2,412
+4% +$260K 1.24% 10
2023
Q2
$6.33M Buy
54,857
+48
+0.1% +$5.45K 1.38% 9
2023
Q1
$5.83M Buy
+54,809
New +$5.92M 1.37% 10

Other funds holding MRK

Sentry LLC's MRK Position: Q1 2026 in Review

Sentry LLC reduced its Merck (MRK) stake by 2.7% in Q1 2026, selling an estimated $151K and leaving 47,853 shares worth $5.76M. The position accounts for 1.83% of the portfolio, ranked #10.

Sentry LLC first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $7.4M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sentry LLC held 47,853 shares of Merck worth $5.76M as of Q1 2026.
  • Sentry LLC sold 1,307 Merck shares in Q1 2026, an estimated $151K.
  • Merck made up 1.83% of Sentry LLC's portfolio in Q1 2026, its #10 holding.
  • Sentry LLC first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • Sentry LLC's Merck position peaked at $7.4M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sentry LLC's 13F filing for Q1 2026, filed 23 Apr 2026.